Related Experiment Video
Updated: Feb 28, 2026

Synthesis of Wavelength-shifting DNA Hybridization Probes by Using Photostable Cyanine Dyes
Published on: July 6, 2016
Engineering Intermolecular Packing of Quinoid-Cyanine Scaffolds for Enhanced Afterglow Brightness and Activatable
Liangyou Zhao1, Yu Wang1, Qingchuan Li1
1School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.
Abstract:
Afterglow luminescence imaging produces long-lasting light emission after excitation ceases, enabling autofluorescence-free imaging with ultrahigh sensitivity. Compared to conventional multicomponent systems, self-sustaining afterglow molecules (SAMs) integrate photosensitization, high-energy intermediate formation, and afterglow generation based on an individual molecule, reducing system complexity and avoiding intermolecular energy transfer, thereby improving simplicity and efficiency. However, self-sustaining afterglow systems often suffer from severe intermolecular interactions, leading to an aggregation-caused quenching (ACQ) effect and suppressed photosensitization capability, ultimately resulting in a compromised afterglow signal. To address these issues, we design self-sustaining quinoid-cyanine-based afterglow scaffolds (QCAs) by incorporating steric hindrance groups to suppress intermolecular interactions and alleviate ACQ. This chemical engineering approach enhances both 1O2 generation and fluorescence, yielding a remarkable 1566-fold increase in afterglow intensity. Theoretical studies confirm that the steric hindrance groups increase the intermolecular distance, yielding looser molecular packing and interactions. Additionally, we introduce a phenylboronic acid moiety into the optimized scaffold to cage the quinone moiety, enabling ONOO--activatable afterglow imaging. The probe enables specific in vivo afterglow imaging of subcutaneous tumors with an ultrahigh signal-to-background ratio (SBR) of 426. Finally, by functionalizing the probe with a blood-brain barrier (BBB)-permeating angiopep-2 peptide, the probe achieves a discriminative detection of mice with Parkinson's disease (PD) from healthy controls with an imaging contrast of 6.5, which is inaccessible with fluorescence imaging. This study presents a systematic chemical engineering strategy for designing SAMs that mitigate intermolecular quenching and enable activatable afterglow luminescence.

